Herman Cain on China: This is not a trade war, it’s a negotiation
Similar Posts
Tehran plays down reported Israeli attacks, signals no retaliation
DUBAI/JERUSALEM, April 19 (Reuters) – Explosions echoed over an Iranian city on Friday in what sources said was an Israeli attack, but Tehran played down the incident and indicated it had no plans for retaliation – a response that appeared gauged towards averting region-wide war. Iran’s foreign minister said the drones, which the sources said…
Exclusive: Major world economies seek to halt new private sector coal financing
BRUSSELS/LONDON, June 7 (Reuters) – Some of the world’s major economies want to finalise a plan ahead of this year’s U.N. climate summit to halt new private sector funding for coal projects, five sources with direct knowledge of the matter told Reuters. If approved, the draft proposal by the Organisation for Economic Co-operation and Development,…
- Breaking News | Israel | News
Israel approves hostage deal with Hamas, agrees to 4-day cease-fire
The deal calls for Hamas to swap women, children for Palestinian prisoners in Israeli jails Nov. 21 (UPI) — The Israeli government voted Tuesday night to approve a hostage deal with Hamas, that allows for the release of 50 women and children being held by militants in Gaza in exchange for a four-day cease-fire, according…
Former UK police officers sentenced for sending racist messages about Meghan, royals
LONDON, Dec 7 (Reuters) – Six former London police officers on Thursday were given suspended prison sentences for sharing offensive and racist messages on WhatsApp, including references to Meghan, the Duchess of Sussex, and other members of the royal family. In a statement after the sentencing hearing Commander James Harman, who leads the Metropolitan Police’s…
Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders
LONDON — Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and rare blood types. Two patients in the U.K. received tiny doses — equivalent to a few teaspoons — of the…
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug
WASHINGTON, Dec 29 (Reuters) – The U.S. Food and Drug Administration failed to adhere to its own guidance and internal practices during the approval process for Biogen’s (BIIB.O) Alzheimer’s drug Aduhelm, which was “rife with irregularities,” a congressional report showed on Thursday. The FDA’s interactions with Biogen were “atypical” and did not follow the agency’s…
